chr3-167790560-G-A
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2
The NM_001122752.2(SERPINI1):c.439G>A(p.Val147Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,710 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. V147V) has been classified as Likely benign.
Frequency
Consequence
NM_001122752.2 missense
Scores
Clinical Significance
Conservation
Publications
- progressive myoclonus epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- familial encephalopathy with neuroserpin inclusion bodiesInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SERPINI1 | NM_001122752.2 | c.439G>A | p.Val147Met | missense_variant | Exon 3 of 9 | ENST00000446050.7 | NP_001116224.1 | |
| SERPINI1 | NM_005025.5 | c.439G>A | p.Val147Met | missense_variant | Exon 3 of 9 | NP_005016.1 | ||
| SERPINI1 | XM_017006618.3 | c.439G>A | p.Val147Met | missense_variant | Exon 3 of 9 | XP_016862107.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SERPINI1 | ENST00000446050.7 | c.439G>A | p.Val147Met | missense_variant | Exon 3 of 9 | 1 | NM_001122752.2 | ENSP00000397373.2 | ||
| SERPINI1 | ENST00000295777.9 | c.439G>A | p.Val147Met | missense_variant | Exon 3 of 9 | 1 | ENSP00000295777.5 | |||
| SERPINI1 | ENST00000472747.2 | c.439G>A | p.Val147Met | missense_variant | Exon 3 of 5 | 3 | ENSP00000420561.2 | |||
| SERPINI1 | ENST00000472941.5 | c.439G>A | p.Val147Met | missense_variant | Exon 3 of 3 | 3 | ENSP00000420133.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152148Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 250944 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461562Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727080 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74330 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Familial encephalopathy with neuroserpin inclusion bodies Uncertain:2
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 147 of the SERPINI1 protein (p.Val147Met). This variant is present in population databases (rs772999261, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SERPINI1-related conditions. ClinVar contains an entry for this variant (Variation ID: 575480). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SERPINI1 protein function.
Inborn genetic diseases Uncertain:1
The c.439G>A (p.V147M) alteration is located in exon 3 (coding exon 2) of the SERPINI1 gene. This alteration results from a G to A substitution at nucleotide position 439, causing the valine (V) at amino acid position 147 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at